By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

A polygenic risk score was able to detect a high proportion of clinically significant prostate cancer. Cancer would not have been detected in 71.8% of patients with the use of PSA or MRI screening.

Greater Manchester Cancer Alliance is one of five cancer alliances to share a £2.25 million cash injection announced by the Small Business Research Initiative (SBRI) Healthcare to fund the scheme. The ...

In the modern era of advanced imaging and genomics testing, the digital rectal exam (DRE) is still an "important" and clinically relevant prognostic test for prostate cancer, conclude the authors of a ...